Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice (original) (raw)

Experimental Investigation of Antibody-Mediated Clearance Mechanisms of Amyloid- in CNS of Tg-SwDI Transgenic Mice

Journal of Neuroscience, 2007

Epitope and isotype specificities of antibodies to -amyloid peptide for protection against Alzheimer's disease-like neuropathology

minh nguyen

Proceedings of The National Academy of Sciences, 2003

View PDFchevron_right

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition

A. Rojiani

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004

View PDFchevron_right

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

kim weiss

Nature Medicine, 2000

View PDFchevron_right

Internalized Antibodies to the Abeta Domain of APP Reduce Neuronal Abeta and Protect against Synaptic Alterations

Camila Almeida

Journal of Biological Chemistry, 2007

View PDFchevron_right

Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models

Yona Levites

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006

View PDFchevron_right

An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease

Dag Sehlin

Neurobiology of Disease, 2009

View PDFchevron_right

Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse model

Ken-ichiro Fukuchi

Biochemical and Biophysical Research Communications, 2006

View PDFchevron_right

Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology

Catherine Canon

Proceedings of the National Academy of Sciences, 2003

View PDFchevron_right

Experimental Investigation of Antibody-Mediated Clearance Mechanisms of Amyloid-β in CNS of Tg-SwDI Transgenic Mice

M. Previti

The Journal of Neuroscience, 2007

View PDFchevron_right

Antibody therapy for Alzheimer's disease

Takeshi Tabira

Clinical Genetics, 1999

View PDFchevron_right

Immunotherapy for Alzheimer's disease: attacking amyloid-â from the inside

Beka Solomon

Trends in Immunology, 2007

View PDFchevron_right

In vivo targeting of antibody fragments to the nervous system for Alzheimer?s disease immunotherapy and molecular imaging of amyloid plaques

Emily Alvarado

Journal of Neurochemistry, 2007

View PDFchevron_right

An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A

Oskar Adolfsson

Journal of Neuroscience, 2012

View PDFchevron_right

Robust Amyloid Clearance in a Mouse Model of AD Provides Novel Insights into the Mechanism of Abeta Immunotherapy

Pritam das

Alzheimer's & Dementia, 2010

View PDFchevron_right

Internalized antibodies to the Aβ domain of APP reduce neuronal Aβ and protect against synaptic alterations

Claudia Almeida

Journal of Biological Chemistry, 2007

View PDFchevron_right

Intravenous immunoglobulins containing antibodies against -amyloid for the treatment of Alzheimer's disease

Yansheng Du

Journal of Neurology, Neurosurgery & Psychiatry, 2004

View PDFchevron_right

Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-A Antibody Administration in PDAPP Mice

Maia Parsadanian

Journal of Neuroscience, 2008

View PDFchevron_right

Optimization of anti-abeta antibody therapy

Rachel Karlnoski

2007

View PDFchevron_right

Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease

xing wei

Journal of Neurology Neurosurgery and Psychiatry, 2004

View PDFchevron_right

Targeting the amyloid-β antibody in the brain tissue of a mouse model of Alzheimer's disease

Molly Shoichet

2012

View PDFchevron_right

Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis

Howard Mount

Nature Medicine, 2002

View PDFchevron_right

Immunological Approach for the Treatment of Alzheimer's Disease

Beka Solomon

Journal of Molecular Neuroscience, 2003

View PDFchevron_right

Immunotherapy for Alzheimer's disease: attacking amyloid-� from the inside

Beka Solomon

Trends Immunol, 2007

View PDFchevron_right

Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer?s disease

Jovan Pavlovic

Journal of Molecular Medicine, 2004

View PDFchevron_right

Anti-Abeta1 11 Antibody Binds to Different beta-Amyloid Species, Inhibits Fibril Formation, and Disaggregates Preformed Fibrils but Not the Most Toxic Oligomers

Irina Petrushina

Journal of Biological Chemistry, 2007

View PDFchevron_right

Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Abeta amyloid burden in a transgenic mouse model of Alzheimer's disease

Raymond S Turner

View PDFchevron_right

Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice (original) (raw)

Related papers